|
TRIP4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.180600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.067900E-02 |
| Normal-vs-Stage2 |
3.202900E-04 |
| Normal-vs-Stage3 |
4.897500E-03 |
| Normal-vs-Stage4 |
4.11769999997258E-06 |
| Stage1-vs-Stage2 |
8.555900E-02 |
| Stage1-vs-Stage3 |
2.097400E-01 |
| Stage1-vs-Stage4 |
6.180400E-03 |
| Stage2-vs-Stage3 |
7.553800E-01 |
| Stage2-vs-Stage4 |
2.454000E-01 |
| Stage3-vs-Stage4 |
2.257200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.100500E-03 |
| Normal-vs-AfricanAmerican |
7.167600E-02 |
| Normal-vs-Asian |
2.661400E-01 |
| Caucasian-vs-AfricanAmerican |
6.558600E-01 |
| Caucasian-vs-Asian |
6.287200E-01 |
| AfricanAmerican-vs-Asian |
4.570800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.336600E-03 |
| Normal-vs-Female |
2.772400E-02 |
| Male-vs-Female |
9.380600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.942200E-02 |
| Normal-vs-Extreme_Weight |
5.83299999999953E-05 |
| Normal-vs-Obese |
1.409640E-01 |
| Normal-vs-Extreme_Obese |
1.028360E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.601000E-01 |
| Normal_Weight-vs-Obese |
9.295600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.136400E-01 |
| Extreme_Weight-vs-Obese |
3.357000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.584800E-01 |
| Obese-vs-Extreme_Obese |
5.648400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.584300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.378200E-02 |
| Normal-vs-Age(61-80Yrs) |
7.220900E-03 |
| Normal-vs-Age(81-100Yrs) |
2.728400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.659600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.893400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.822800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.714400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.793200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.881600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.947640E-02 |
| Normal-VS-Type2 PRCC |
1.924040E-01 |
| Normal-VS-KIRP CIMP |
2.7105995226151E-10 |
| Normal-VS-Unclassified PRCC |
2.523900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.199000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.56479999647541E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
2.738800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.11810000000568E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
5.481000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.90410000000729E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.607300E-04 |
| Normal-vs-N1 |
5.500100E-02 |
| Normal-vs-N2 |
5.73309999474247E-08 |
| N0-vs-N1 |
5.891200E-01 |
| N0-vs-N2 |
9.902100E-03 |
| N1-vs-N2 |
1.708120E-02 |
|
|
